Migraine genetics

Expert Review of Neurotherapeutics

Volumn 8, Issue 9, 2008, Pages 1321-1330

  Montagna, Pasquale ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Epigenetic; Familial hemiplegic migraine; Genetic association; Genetic linkage; Genetics; Genome wide scan; Headache; Migraine; Pharmacogenetic; Sickness behavior

Indexed keywords

ATP1A2 GENE; AUTOSOMAL DOMINANT INHERITANCE; CACNA1A GENE; CHROMOSOME ANALYSIS; DNA SEQUENCE; ENVIRONMENTAL FACTOR; EPIGENETICS; FAMILIAL HEMIPLEGIC MIGRAINE; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HEMIPLEGIC MIGRAINE; HUMAN; INFARCTION; MIGRAINE; MIGRAINE AURA; MUTATOR GENE; PATHOGENESIS; PREVALENCE; REVIEW; SCN1A GENE; SOCIAL STATUS; TRANSFORMED MIGRAINE; TWINS;

EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MIGRAINE DISORDERS;

EID: 51149099586     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.9.1321     Document Type: Review

References (111)

1. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 24, 1-160 (2004).
2. Russell MB, Iselius L, Olesen J. Migraine without aura and migraine with aura are inherited disorders. Cephalalgia 16, 305-309 (1996).
3. Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB. Evidence for a genetic factor in migraine with aura: a population-based Danish twin study. Ann. Neurol. 45, 242-246 (1999).
4. Russell MB, Ulrich V, Gervil M, Olesen J. Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache 42, 332-336 (2002).
5. Bigal ME, Lipton RB, Winner P et al. Migraine in adolescents: association with socioeconomic status and family history. Neurology 69, 16-25 (2007).
6. Ulrich V, Olesen J, Gervil M, Russell MB. Possible risk factors and precipitants for migraine with aura in discordant twin-pairs: a population-based study. Cephalalgia 20, 821-825 (2000).
7. Devoto M, Lozito A, Staffa G, D'Alessandro R, Sacquegna T, Romeo G. Segregation analysis of migraine in 128 families. Cephalalgia 6, 101-105 (1986).
8. Mochi M, Sangiorgi S, Cortelli P et al. Testing models for genetic determination in migraine. Cephalalgia 13, 389-394 (1993).
9. Russell MB, Iselius L, Olesen J. Inheritance of migraine investigated by complex segregation analysis. Hum. Genet. 96, 726-730 (1995).
10. Merikangas KR, Merikangas JR, Angst J. Headache syndromes and psychiatric disorders: association and familial transmission. J. Psychiatr. Res. 27, 197-210 (1993).
11. Chen TC, Leviton A. Asthma and eczema in children born to women with migraine. Arch. Neurol. 47, 1227-1230 (1990).
12. Gurkan F, Ece A, Haspolat K, Dikici B. Parental history of migraine and bronchial asthma in children. Allergol. Immunopathol. (Madr.) 28, 15-17 (2000).
13. Mortimer MJ, Kay J, Gawkrodger DJ, Jaron A, Barker DC. The prevalence of headache and migraine in atopic children: an epidemiological study in general practice. Headache 33, 427-431 (1993).
14. Wessman M, Kallela M, Kaunisto MA et al. A susceptibility locus for migraine with aura, on chromosome 4q24. Am. J. Hum. Genet. 70, 652-662 (2002).
15. Cader ZM, Noble-Topham S, Dyment DA et al. Significant linkage to migraine with aura on chromosome 11q24. Hum. Mol. Genet. 12, 2511-2517 (2003).
16. Russo L, Mariotti P, Sangiorgi E et al. A new susceptibility locus for migraine with aura in the 15q11-q13 genomic region containing three GABA-A receptor genes. Am. J. Hum. Genet. 76, 327-333 (2005).
17. Soragna D, Vettori A, Carraro G et al. A locus for migraine without aura maps on chromosome 14q21.2-q22.3. Am. J. Hum. Genet. 72, 161-167 (2003).
18. Carlsson A, Forsgren L, Nylander PO et al. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology 59, 1804-1807 (2002).
19. Nyholt DR, Dawkins JL, Brimage PJ, Goadsby PJ, Nicholson GA, Griffiths LR. Evidence for an X-linked genetic component in familial typical migraine. Hum. Mol. Genet. 7, 459-463 (1998).
20. Nyholt DR, Curtain RP, Griffiths LR. Familial typical migraine: significant linkage and localization of a gene to Xq24-28. Hum. Genet. 107, 18-23 (2000).
21. Bjornsson A, Gudmundsson G, Gudfinnsson E et al. Localization of a gene for migraine without aura to chromosome 4q21. Am. J. Hum. Genet. 73, 986-993 (2003).
22. McCarthy LC, Hosford DA, Riley JH et al. Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics 78, 135-149 (2001).
23. Curtain R, Tajouri L, Lea R, Macmillan J, Griffiths L. No mutations detected in the INSR gene in a chromosome 19p13 linked migraine pedigree. Eur. J. Med. Genet. 49, 57-62 (2006).
24. Mochi M, Cevoli S, Cortelli P et al. Investigation of an LDLR gene polymorphism (19p13.2) in susceptibility to migraine without aura. J. Neurol. Sci. 213, 7-10 (2003).
25. Curtain R, Lea RA, Quinlan S et al. Investigation of the low-density lipoprotein receptor gene and cholesterol as a risk factor for migraine. J. Neurol. Sci. 227, 95-100 (2004).
26. Montagna P. The primary headaches: genetics, epigenetics and a behavioural genetic model. J. Headache Pain 9, 57-69 (2008)
27. Joutel A, Bousser MG, Biousse V et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat. Genet. 5, 40-45 (1993).
28. Ophoff RA, Terwindt GM, Vergouwe MN et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87, 543-552 (1996).
29. 2+ channel mutation. Brain 123, 463-471 (2000).
30. Zhuchenko O, Bailey J, Bonnen P et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat. Genet. 15, 62-69 (1997).
31. Gardner K, Barmada MM, Ptacek LJ, Hoffman EP. A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology 49, 1231-1238 (1997).
32. Ducros A, Joutel A, Vahedi K et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann. Neurol. 42, 885-890 (1997).
33. + pump α2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33, 192-196 (2003).
34. Dichgans M, Freilinger T, Eckstein G et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366, 371-377 (2005).
35. Terwindt GM, Ophoff RA, Haan J, Sandkuijl LA, Frants RR, Ferrari MD. Migraine, ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies. Dutch Migraine Genetics Research Group. Eur. J. Hum. Genet. 6, 297-307 (1998).
36. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat. Rev. Neurosci. 4, 386-398 (2003).
37. van den Maagdenberg AM, Pietrobon D, Pizzorusso T et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41, 701-710 (2004).
38. May A, Ophoff RA, Terwindt GM et al. Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum. Genet. 96, 604-608 (1995).
39. Terwindt GM, Ophoff RA, van Eijk R et al. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology 56, 1028-1032 (2001).
40. Todt U, Dichgans M, Jurkat-Rott K et al. Rare missense variants in ATP1A2 in families with clustering of common forms of migraine. Hum. Mutat. 26, 315-321 (2005).
41. Hovatta I, Kallela M, Färkkilä M, Peltonen L. Familial migraine: exclusion of the susceptibility gene from the reported locus of familial hemiplegic migraine on 19p. Genomics 23, 707-709 (1994).
42. Monari L, Mochi M, Valentino ML et al. Searching for migraine genes: exclusion of 290 cM out of the whole human genome. Ital. J. Neurol. Sci. 18, 277-282 (1997).
43. Kim JS, Yue Q, Jen JC, Nelson SF, Baloh RW. Familial migraine with vertigo: no mutations found in CACNA1A. Am. J. Med. Genet. 79, 148-151 (1998).
44. Noble-Topham SE, Dyment DA, Cader MZ et al. Migraine with aura is not linked to the FHM gene CACNA1A or the chromosomal region, 19p13. Neurology 59, 1099-1101 (2002).
45. Jones KW, Ehm MG, Pericak-Vance MA, Haines JL, Boyd PR, Peroutka SJ. Migraine with aura susceptibility locus on chromosome 19p13 is distinct from the familial hemiplegic migraine locus. Genomics 78, 150-154 (2001).
46. Brugnoni R, Leone M, Rigamonti A et al. Is the CACNA1A gene involved in familial migraine with aura? Neurol. Sci. 23, 1-5 (2002).
47. Wieser T, Mueller C, Evers S, Zierz S, Deufel T. Absence of known familial hemiplegic migraine (FHM) mutations in the CACNA1A gene in patients with common migraine: implications for genetic testing. Clin. Chem. Lab. Med. 41, 272-275 (2003).
48. Jen JC, Kim GW, Dudding KA, Baloh RW. No mutations in CACNA1A and ATP1A2 in probands with common types of migraine. Arch. Neurol. 61, 926-928 (2004).
49. Curtain RP, Lea RA, Tajouri L et al. Analysis of chromosome 1 microsatellite markers and the FHM2-ATP1A2 gene mutations in migraine pedigrees. Neurol. Res. 27, 647-652 (2005).
50. von Brevern M, Ta N, Shankar A et al. Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache 46, 1136-1141 (2006).
51. Netzer C, Todt U, Heinze A et al. Haplotype-based systematic association studies of ATP1A2 in migraine with aura. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141, 257-260 (2006).
52. Kirchmann M, Thomsen LL, Olesen J. The CACNA1A and ATP1A2 genes are not involved in dominantly inherited migraine with aura. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141, 250-256 (2006).
53. Thomsen LL, Kirchmann M, Bjornsson A et al. The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain 130, 346-356 (2007).
54. Terwindt G, Kors E, Haan J et al. Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine. Arch. Neurol. 59, 1016-1018 (2002).
55. Thomsen L, Oestergaard E, Bjornsson A et al. Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients. Cephalalgia (2008) (Epub ahead of print).
56. de Vries B, Freilinger T, Vanmolkot KR et al. Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine. Neurology 69, 2170-2176 (2007).
57. Jouvenceau A, Eunson LH, Spauschus A et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358, 801-807 (2001).
58. +-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann. Neurol. 54, 360-366 (2003).
59. Kors EE, Melberg A, Vanmolkot KR et al. Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology 63, 1136-1137 (2004).
60. Beauvais K, Cave-Riant F, De Barace C, Tardieu M, Tournier-Lasserve E, Furby A. New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus. Eur. Neurol. 52, 58-61 (2004).
61. Ducros A, Denier C, Joutel A et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N. Engl. J. Med. 345, 17-24 (2001).
62. Cevoli S, Pierangeli G, Monari L et al. Familial hemiplegic migraine: clinical features and probable linkage to chromosome 1 in an Italian family. Neurol. Sci. 23, 7-10 (2002).
63. + ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics 5, 177-185 (2004).
64. Kors EE, Terwindt GM, Vermeulen FL et al. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann. Neurol. 49, 753-760 (2001).
65. Echenne B, Ducros A, Rivier F et al. Recurrent episodes of coma: an unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1. Neuropediatrics 30, 214-217 (1999).
66. Spranger M, Spranger S, Schwab S, Benninger C, Dichgans M. Familial hemiplegic migraine with cerebellar ataxia and paroxysmal psychosis. Eur. Neurol. 41, 150-152 (1999).
67. Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev. Med. Child Neurol. 44, 490-493 (2002).
68. Swoboda KJ, Kanavakis E, Xaidara A et al. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. Ann. Neurol. 55, 884-887 (2004).
69. +-ATPase variants. Neurology 62, 1857-1861 (2004).
70. Vanmolkot KR, Stroink H, Koenderink JB et al. Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation. Ann. Neurol. 59, 310-314 (2006).
71. Bassi MT, Bresolin N, Tonelli A et al. A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. J. Med. Genet. 41, 621-628 (2004).
72. Auvin S, Joriot-Chekaf S, Cuvellier JC, Vallée L. Familial alternating hemiplegia of childhood or channelopathy? A report with valuable pathophysiological implications. Dev. Med. Child Neurol. 46, 500 (2004).
73. Kaja S, van de Ven RC, Broos LA et al. Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness. Neuroscience 135, 81-95 (2005).
74. Kaja S, van de Ven RC, van Dijk JG et al. Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya. Eur. J. Neurosci. 25, 2009-2020 (2007).
75. Montagna P, Gallassi R, Medori R et al. MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology 38, 751-754 (1988).
76. Goto Y, Horai S, Matsuoka T et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 42, 545-550 (1992).
77. Chabriat H, Vahedi K, Iba-Zizen MT et al. Clinical spectrum of CADASIL: a study of 7 families. Lancet 346, 934-939 (1995).
78. Dichgans M, Mayer M, Uttner I. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann. Neurol. 44, 731-739 (1998).
79. Ophoff RA, DeYoung J, Service SK et al. Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. Am. J. Hum. Genet. 69, 447-453 (2001).
80. Michael JC, Levin PM. Multiple telangiectases of brain: a discussion of hereditary factors in their development. Arch. Neurol. Psychiat. 36, 514-536 (1936).
81. Marini V, Ferrera L, Dorcaratto A. Identification of a novel KRIT1 mutation in an Italian family with cerebral cavernous malformation by the protein truncation test. J. Neurol. Sci. 212, 75-78 (2003).
82. Bonifati V, Oostra BA, Heutink P. Unraveling the pathogenesis of Parkinson's disease - the contribution of monogenic forms. Cell. Mol. Life Sci. 61, 1729-1750 (2004).
83. Stefansson H, Rye DB, Hicks A et al. A genetic risk factor for periodic limb movements in sleep. N. Engl. J. Med. 357, 639-647 (2007).
84. Winkelmann J, Schormair B, Lichtner P et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat. Genet. 39, 1000-1006 (2007).
85. Isles AR and Wilkinson LS. Epigenetics: what is it and why is it important to mental disease? Br. Med. Bull. 85, 35-45 (2008).
86. Luedi PP, Dietrich FS, Weidman JR, Bosko JM, Jirtle LR, Hartemink AJ. Computational and experimental identification of novel human imprinted genes. Genome Res. 17, 1723-1730 (2007).
87. Oommen AM, Griffin JB, Sarath G, Zempleni J. Roles for nutrients in epigenetic events. J. Nutr. Biochem. 16, 74-77 (2005).
88. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 8, 253-262 (2007).
89. Fraga MF, Ballestar E, Paz MF et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. USA 102, 10604-10609 (2005).
90. Francis DD, Szegda K, Campbell G, Martin WD, Insel TR. Epigenetic sources of behavioral differences in mice. Nat. Neurosci. 6, 445-446 (2003).
91. Weaver IC, Cervoni N, Champagne FA et al. Epigenetic programming by maternal behaviour. Nat. Neurosci. 7, 847-854 (2004).
92. Champagne FA, Weaver IC, Diorio J, Dymov S, Szyf M, Meaney MJ. Maternal care associated with methylation of the estrogen receptor alpha1b promoter and estrogen receptor alpha expression in the medial preoptic area of female offsprings. Endocrinology 147, 2909-2915 (2006).
93. Gianfrancesco F, Esposito T. The molecular genetics of migraine: toward the identification of responsible genes. Curr. Genomics 7, 1-10 (2006).
94. Weaver IC, Champagne FA, Brown SE et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J. Neurosci. 25, 11045-11054 (2005).
95. Laird PW. Cancer epigenetics. Hum. Mol. Genet. 14, R65-R76 (2005).
96. Dong E, Agis-Balboa RC, Simonini MV, Grayson DR, Costa E, Guidotti A. Reelin and glutamic acid decarboxylase promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc. Natl Acad. Sci. USA 102, 12578-12583 (2005).
97. Schurks M. Epigenetics in primary headaches: a new avenue for research. J. Headache Pain 9, 191-192 (2008).
98. Montagna P. Epigenetics and pharmacoepigenetics in the primary headaches. J. Headache Pain 9, 193-194 (2008).
99. Montagna P, Cortelli P. Migraine and the autonomic nervous system. In: Clinical Autonomic Disorders: Evaluation and Management. Low PA (Ed.), Lippincott, Williams and Wilkins (2008) (In Press).
100. Wilson SG, Bryant CD, Lariviere WR et al. The heritability of antinociception II: pharmacogenetic mediation of three over-the-counter analgesics in mice. J. Pharmacol. Exp. Ther. 305, 755-764 (2003).
101. Chesler EJ, Ritchie J, Kokayell A, Lariviere WR, Wilson SG, Mogil JS. Genotype-dependence of gabapentin and pregabalin sensitivity: the pharmacogenetic mediation of analgesia is specific to the type of pain being inhibited. Pain 106, 325-335 (2003).
102. Terner JM, Lomas LM, Smith ES, Barrett AC, Picker MJ. Pharmacogenetic analysis of sex differences in opioid antinociception in rats. Pain 106, 381-391 (2003).
103. Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA 286(18), 2270-2279 (2001).
104. Maassen VanDenBrink A, Vergouwe MN, Ophoff RA et al. Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients. Am. J. Med. Genet. 77, 415-420 (1998).
105. 1B receptor polymorphism and clinical response to sumatriptan. Headache 38, 288-291 (1998).
106. Schurks M, Kurth T, Stude P et al. G protein β3 polymorphism and triptan response in cluster headache. Clin. Pharmacol. Ther. 82, 396-401 (2007).
107. Montagna P, Pierangeli G, Cevoli S, Mochi M, Cortelli P. Pharmacogenetics of headache treatment. Neurol. Sci. 26, S143-S147 (2005).
108. Tegeder I, Costigan M, Griffin RS et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat. Med. 12, 1269-1277 (2006).
109. Fertleman CR, Baker MD, Parker KA et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52, 767-774 (2006).
110. Cox JJ, Reimann F, Nicholas AK et al. An SCN9A channellopathy causes congenital inability to experience pain. Nature 444, 894-898 (2006).
111. Catterall WA, Yu FH. Painful channels. Neuron 52, 743-744 (2006).